| 专利名称 | COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER | ||
| 申请号 | JP2019034057 | 申请日 | |
| 公开（公告）号 | JP2019104747A | 公开（公告）日 | |
| 申请（专利权）人 | GANYMED PHARMACEUTICALS GMBH; TRON TRANSLATIONALE ONKOLOGIE AN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ GEMEINNUETZIGE GMBH | 发明人 | UGUR SAHIN; OZLEM TUERECI; RITA MITNACHT KRAUS; STEFAN DENIS JACOBS; MAGDALENA JADWIGA UTSCH; CORNELIA ADRIANA MARIA HEINZ; CHRISTIANE REGINA STADLER |
| 专利来源 | 国家知识产权局 | 转化方式 | |
| 摘要 |
PROBLEM TO BE SOLVED : To provide a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2.SOLUTION : The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head and neck cancer, and cancer of the gallbladder and metastases thereof.SELECTED DRAWING : NoneCOPYRIGHT : (C)2019, JPO&INPIT |
||
主管部门：海南中小企业服务 | 建设单位：海南商业联合会
版权所有：海南商业联合会 | 备案号：粤ICP备13083911号（ICP加挂服务）@2017
